Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
During Q2 2025, the Hardman Johnston Global Equity Composite returned 16.72% net of fees, handily outperforming the MSCI AC World Net Index's return of 11.53%. This strong relative...
— Cassandra A. Hardman
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Vertex Pharmaceuticals Incorporated
No other institutional pitches found for this ticker yet.